Basit öğe kaydını göster

dc.contributor.authorKilickesmez, Kadriye Orta
dc.contributor.authorKaya, Aysem
dc.contributor.authorKucukoglu, Serdar
dc.contributor.authorKocas, Cuneyt
dc.contributor.authorAbaci, Okay
dc.contributor.authorYildiz, Ahmet
dc.contributor.authorOkcun, Baris
dc.date.accessioned2021-03-04T11:31:40Z
dc.date.available2021-03-04T11:31:40Z
dc.date.issued2012
dc.identifier.citationKilickesmez K. O. , Abaci O., Kocas C., Yildiz A., Kaya A., Okcun B., Kucukoglu S., "Dilatation of the ascending aorta and serum alpha 1-antitrypsin level in patients with bicuspid aortic valve", HEART AND VESSELS, cilt.27, sa.4, ss.391-397, 2012
dc.identifier.issn0910-8327
dc.identifier.otherav_72bea7fb-c59a-4858-b7d5-aed1eb0f9e8f
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/78979
dc.identifier.urihttps://doi.org/10.1007/s00380-011-0161-1
dc.description.abstractPredictors of aortic dilatation are not well described in patients with bicuspid aortic valves (BAV). This study sought to examine the relationship between proximal aortic dilatation and matrix metalloproteinase-9 (MMP-9) and alpha 1-antitrypsin (alpha 1AT) levels in patients with BAV. All patients underwent echocardiography using a standard protocol, and aortic measurements were taken in end-diastole. We studied 82 patients with BAV and categorized them into two groups according to aortic dimensions corrected for body surface area and age. The plasma level of alpha 1AT was routinely determined using a BN ProSpec analyzer (Siemens Healthcare Diagnostics, Marburg, Germany), and that of MMP-9 were determined by ELISA (RayBiotech Inc. Norcross, GA, USA). Statistical analysis was performed using the Statistical Package for Social Sciences (SPSS; SPSS Inc., Chicago, IL, USA) software for Windows version 12. This study included patients with BAV with no or mild valvular impairment. There were no significant differences between groups in terms of gender, body surface area, associated hypertension, diabetes mellitus, hyperlipidemia, or smoking. The mean ascending aortic diameter was 4.38 +/- A 0.5 mm in group 1 and 3.34 +/- A 0.35 mm in group 2 (p < 0.001). Plasma concentration of alpha 1AT in patients with ascending aortic dilatation was significantly lower than that in the non-dilated group (1.32 +/- A 0.27 and 1.49 +/- A 0.25 g/l, respectively; p = 0.005). However, no significant difference was found in the MMP-9 level between the two groups (336.49 +/- A 233.11 and 336.39 +/- A 268.072 pg/ml, respectively; p = 0.96). We observed a significantly negative correlation between ascending aortic diameter and alpha 1AT level (r = -0.300, p = 0.006) and a positive correlation between ascending aortic diameter and age (r = 0.413, p < 0.001). No significant correlation was found between plasma MMP-9 concentration and ascending aortic diameter (r = -0.008, p = 0.94). A multiple linear regression analysis was performed, including age, alpha 1AT level, MMP-9 level, and left ventricular diastolic diameter. In this analysis, alpha 1AT level and age were the independent predictors of aortic dilatation (p = 0.03 and p = 0.02, respectively).
dc.language.isoeng
dc.subjectTıp
dc.subjectKardiyoloji
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectPERİFERAL VASKÜLER HASTALIĞI
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectCARDIAC ve CARDIOVASCULAR SİSTEMLER
dc.titleDilatation of the ascending aorta and serum alpha 1-antitrypsin level in patients with bicuspid aortic valve
dc.typeMakale
dc.relation.journalHEART AND VESSELS
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume27
dc.identifier.issue4
dc.identifier.startpage391
dc.identifier.endpage397
dc.contributor.firstauthorID92360


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster